Skip to main content

Table 4 Tumor characteristics (based on final pathology)

From: The impact of use of an intraoperative margin assessment device on re-excision rates

Tumor composition

ā€ƒIDC

37

22.4%

ā€ƒDCIS

32

19.4%

ā€ƒIDCā€‰+ā€‰DCIS

75

45.5%

ā€ƒILC

11

6.7%

ā€ƒILCā€‰+ā€‰DCIS

1

0.6%

ā€ƒIPC

2

1.2%

ā€ƒITC

4

2.4%

ā€ƒITCā€‰+ā€‰DCIS

1

0.6%

ā€ƒPCIS

1

0.6%

ā€ƒMetastatic sarcoma

1

0.6%

Tumor grade:

Ā Ā 

ā€ƒInvasive grade

ā€ƒā€ƒ1

41

35%

ā€ƒā€ƒ2

56

47%

ā€ƒā€ƒ3

21

18%

ā€ƒIn-Situ grade

ā€ƒā€ƒ1

20

20%

ā€ƒā€ƒ2

52

51%

ā€ƒā€ƒ3

29

29%

Tumor/lesion size (cm)

ā€ƒMean (STD)

1.5 (1.1)

Ā 

ā€ƒ<1

51

35%

ā€ƒ1 to 2

58

40%

ā€ƒ>2

35

24%

  1. IDC: Invasive Ductal Carcinoma; ILC: Invasive Lobular Carcinoma; DCIS: Ductal Carcinoma In-situ; IPC: Invasive Papillary Carcinoma; ITC: Invasive Tubular Carcinoma; PCIS: Papillary Carcinoma In-situ.